Quality measures for the care of patients with narcolepsy

Journal of Clinical Sleep Medicine

Volumn 11, Issue 3, 2015, Pages 335-355

  Krahn, Lois E ^a   Hershner, Shelley ^b   Loeding, Lauren D ^c   Maski, Kiran P ^d   Rifkin, Daniel I ^e   Selim, Bernardo ^f   Watson, Nathaniel F ^g  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c American Academy of Sleep Medicine   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSESSMENT OF HUMANS; CLEVELAND ADOLESCENT SLEEPINESS QUESTIONNAIRE; COMORBIDITY; DAYTIME SOMNOLENCE; DIAGNOSTIC ACCURACY; EPWORTH SLEEPINESS SCALE; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; INTERPERSONAL COMMUNICATION; KAROLINSKA SLEEPINESS SCALE; NARCOLEPSY; PATIENT CARE; PATIENT COUNSELING; PATIENT SAFETY; STANFORD SLEEPINESS SCALE; VISUAL ANALOG SCALE; WAKEFULNESS; ADOLESCENT; ADULT; CHILD; COMPLICATION; HEALTH CARE QUALITY; SLEEP MEDICINE; STANDARDS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; HUMANS; NARCOLEPSY; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; SLEEP MEDICINE SPECIALTY; TREATMENT OUTCOME;

EID: 84924857435     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.4554     Document Type: Article

References (42)

1. Longstreth WT Jr., Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007;30:13-26.
2. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010;33:1457-64.
3. Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsycataplexy across ethnic groups. Sleep 2002;25:27-35.
4. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
5. Morgenthaler TI, Aronsky AJ, Carden KA, Chervin RD, Thomas SM, Watson NF. Measurement of quality to improve care in sleep medicine. J Clin Sleep Med 2015;11:279-91.
6. Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:1705-11.
7. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976.
8. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540-5.
9. Schwartz JR, Khan A, McCall WV, Weintraub J, Tiller J. Tolerability and efficacy of armodafinil in naive patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period. J Clin Sleep Med 2010;6:450-7.
10. Harsh JR, Hayduk R, Rosenberg R, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin 2006;22:761-74.
11. Weaver TE, Cuellar N. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006;29:1189-94.
12. Mitler MM, Harsh J, Hirshkowitz M, Guilleminault C. Long-term efficacy and safety of modafinil (PROVIGIL (R)) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 2000;1:231-43.
13. Ozaki A, Inoue Y, Hayashida K, et al. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population. Sleep Med 2012;13:200-6.
14. Wise MS, Arand DL, Auger RR, Brooks SN, Watson NF, American Academy of Sleep Medicine. Treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:1712-27.
15. Schulz H, Lund R. On the origin of early REM episodes in the sleep of depressed patients: a comparison of three hypotheses. Psychiatry Res 1985;16:65-77.
16. Plazzi G, Pizza F, Palaia V, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134(Pt 12):3480-92.
17. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005;9:269-310.
18. Aurora RN, Lamm CI, Zak RS, et al. Practice parameters for the nonrespiratory indications for polysomnography and multiple sleep latency testing for children. Sleep 2012;35:1467-73.
19. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21.
20. Mignot E, Lin L, Finn L, et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006;129(Pt 6):1609-23.
21. Chervin RD, Aldrich MS. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med 2000;161(2 Pt 1):426-31.
22. Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 2013;14:488-92.
23. Inocente CO, Lavault S, Lecendreux M, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013;19:521-8.
24. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996;74:511-44.
25. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775-9.
26. Tsai AC, Morton SC, Mangione CM, Keeler EB. A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care 2005;11:478-88.
27. Karter AJ, Parker MM, Moffet HH, et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care 2004;42:110-5.
28. Guilleminault C. Amphetamines and narcolepsy: use of the Stanford database. Sleep 1993;16:199-201.
29. Hood B, Bruck D. A comparison of sleep deprivation and narcolepsy in terms of complex cognitive performance and subjective sleepiness. Sleep Med 2002;3:259-66.
30. Hegmann KT, Andersson GB, Greenberg MI, Phillips B, Rizzo M. FMCSA's medical review board: five years of progress in commercial driver medical examinations. J Occup Environ Med 2012;54:424-30.
31. Marino M, de Belvis A, Basso D, et al. Interventions to evaluate fitness to drive among people with chronic conditions: systematic review of literature. Accid Anal Prev 2013;50:377-96.
32. Kotterba S, Mueller N, Leidag M, et al. Comparison of driving simulator performance and neuropsychological testing in narcolepsy. Clin Neurol Neurosurg 2004;106:275-9.
33. Helmus T, Rosenthal L, Bishop C, Roehrs T, Syron ML, Roth T. The alerting effects of short and long naps in narcoleptic, sleep deprived, and alert individuals. Sleep 1997;20:251-7.
34. Teixeira VG, Faccenda JF, Douglas NJ. Functional status in patients with narcolepsy. Sleep Med 2004;5:477-83.
35. Mullington J, Broughton R. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy. Sleep 1993;16:444-56.
36. Rogers AE, Aldrich MS, Lin X. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep 2001;24:385-91.
37. National Highway Traffic Safety A. The contribution of medical conditions to passenger vehicle crashes. Ann Emerg Med 2010;55:563-4.
38. Philip P, Chaufton C, Taillard J, et al. Maintenance of wakefulness test scores and driving performance in sleep disorder patients and controls. Int J Psychophysiol 2013;89:195-202.
39. Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 1981;8:299-304.
40. Kales A, Soldatos CR, Bixler EO, et al. Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol 1982;39:169-71.
41. American Academy of Sleep Medicine. Standards for accreditation. 2014.
42. American Board of Psychiatry and Neurology, Inc. Maintenance of certification in sleep medicine. 2014. http://www.abpn.com/moc-sm.asp.